Rubius Therapeutics Inc (OTC Pink - Current Information:RUBY)
| 0.0153 Delayed Data As of Mar 24 |  -0.0006 / -3.77%Today’s Change | 0.01 Today|||52-Week Range 6.18 | -91.26% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2018 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 275.0K | 377.0K | 384.0K | 661.0K | ||
| Operating Expenses | Gross Income | -275.0K | -377.0K | -384.0K | -661.0K | |
| General Expenses | 28.0M | 27.2M | 28.7M | 33.7M | ||
| Research And Development | 12.0M | 14.4M | 16.5M | 20.9M | ||
| Total Operating Expenses | 28.2M | 27.6M | 29.1M | 34.4M | ||
| Non-Operating Expenses | Operating Income | -28.2M | -27.6M | -29.1M | -34.4M | |
| Extraordinary Charge | -1.7M | -426.0K | 0.00 | 0.00 | ||
| Interest Expense On Debt | 89.0K | 87.0K | 205.0K | 583.0K | ||
| Other Expenses | 0.00 | 0.00 | 2.1M | 108.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -29.1M | -26.4M | -27.2M | -32.6M | |
| Net Income | -29.1M | -26.4M | -27.2M | -32.6M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 8.7M | 62.3M | 76.7M | 77.5M | |
| Shares To Calculate EPS Diluted | 8.7M | 62.3M | 76.7M | 77.5M | ||
| Earnings Per Share | EPS | -$3.33 | -$0.42 | -$0.35 | -$0.42 | |
| EPS Diluted | -$3.33 | -$0.42 | -$0.35 | -$0.42 | ||
